Ondo Finance completes acquisition of Oasis Pro, obtains SEC license to expand into the U.S. tokenized securities market
ChainCatcher news, RWA (Real World Asset) tokenization protocol Ondo Finance announced that it has successfully completed the acquisition of the regulated digital asset broker-dealer Oasis Pro.
This strategic acquisition enables Ondo Finance to obtain a comprehensive set of licenses and infrastructure, including an SEC-registered broker-dealer, Alternative Trading System (ATS), and Transfer Agent (TA), allowing it to develop and offer regulated tokenized securities markets within the United States. Oasis Pro's infrastructure supports the tokenization, issuance, transfer, and secondary trading of RWAs, and is one of the first US-regulated ATSs authorized to use stablecoins for digital securities settlement. Ondo CEO Nathan Allman stated that through this merger, Ondo is committed to building a transparent, accessible, and compliant on-chain financial system and accelerating the development of the US tokenized securities market.
.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Janus Henderson Macro Head Says Market Is Near Its Top but Cannot Say When
A $5.7 billion patent verdict has been issued, Burford Capital (BUR.US) may receive $1.4 billion, and its share price soared by more than 12%.
Burford Capital Ltd. surged more than 12% on Monday, marking its largest intraday increase since the end of March, after a federal jury delivered a verdict in a patent case involving Apple.
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
